The present outbreak of a coronavirus-associated acute respiratory disease called coronavirus disease 19 (COVID-19) is the third documented spillover of an animal coronavirus to humans in only two decades that has resulted in a major epidemic.
Pregnant women require particular attention in term of emerging infections because of their relative immunosuppressed state and restricted respiratory capacity. Consequences of infection with SARS-CoV-2 for pregnant women are uncertain, as epidemiological and clinical information is missing so far in this population. Therefore, a reliable data collection aiming to better characterise the risks associated to SARS-CoV-2 infection in pregnancy should be set up during the current epidemic. Information issued from such an initiative will allow to develop the evidence based clinical recommendations for the care of SARS-CoV-2 infected pregnant women that are missing so far.
The purpose of COVI-PREG is:
Inclusion criteria: any pregnant patient SUSPECTED OF SARS-CoV-2 infection during pregnancy.
The data collected and coded will be made available to any research group in the world following the data-sharing agreement initiative, provided that they have a clear, non-redundant research question and a biomedical research Ethics committee approval (a list of on-going research projects will be kept available). Anyone supporting the registry by providing well-documented cases will be listed as a collaborator of the COVI-PREG registry in any future peer reviewed scientific publication having used data from the registry.
If you are willing to collaborate, please fill in the information required to get an access to the registry below.